CPhI Online

- Market News

Cambrex names Troy Player as head of early stage development and testing

31 Mar 2020

Cambrex has appointed pharma industry veteran, Troy Player, as president, early stage development and testing, the contract development and manufacturing organisation said Tuesday.

In his new role, Player will be responsible for operations at Cambrex’s facilities in Agawam in Massachusetts, Durham and High Point in North Carolina, Edinburgh in Scotland and Longmont in Colorado.

Player was previously at West Pharmaceuticals where he spent 17 years and was most recently vice president and general manager of the contract manufacturing business unit where he oversaw six manufacturing locations and two engineering development centers. Prior to this he oversaw West’s Asia Pacific business.

“I am pleased to welcome an operational excellence and continuous improvement expert like Troy to our team,” said Shawn Cavanagh, president and chief operating officer at Cambrex. “He is well-versed in leading cross-functional business improvement within commercial, manufacturing, customer service, business development, logistics/procurement, and product management/development environments, which makes him an invaluable asset to our team.”

The ESD&T business unit was integrated into the Cambrex service portfolio following the acquisition of Avista Pharma Solutions in January 2019.